Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has issued an update.
Proteomics International Laboratories Ltd announced that its Managing Director, Dr. Richard Lipscombe, and Chief Commercial Officer, Mr. Phillip Prather, will present at the Morgan Stanley Alpha ex-100 Conference in Sydney. This participation underscores the company’s active engagement with investors and highlights its leadership in the field of predictive diagnostics, potentially enhancing its market visibility and stakeholder interest.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, based in Perth, Western Australia, is a medical technology company specializing in precision diagnostics and bio-analytical services. The company focuses on proteomics, which involves the large-scale study of protein structures and functions, aiming to enhance disease treatment through innovative diagnostic tools.
YTD Price Performance: -47.50%
Average Trading Volume: 131,294
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$55.02M
See more data about PIQ stock on TipRanks’ Stock Analysis page.